145 related articles for article (PubMed ID: 38098267)
21. Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9.
Hara H; Ishihara C; Takeuchi A; Xue L; Morris SW; Penninger JM; Yoshida H; Saito T
J Immunol; 2008 Jul; 181(2):918-30. PubMed ID: 18606643
[TBL] [Abstract][Full Text] [Related]
22. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
[TBL] [Abstract][Full Text] [Related]
23. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
Wegener E; Krappmann D
Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
[TBL] [Abstract][Full Text] [Related]
24. Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist.
Cheng J; Maurer LM; Kang H; Lucas PC; McAllister-Lucas LM
Cell Immunol; 2020 Sep; 355():104158. PubMed ID: 32721634
[TBL] [Abstract][Full Text] [Related]
25. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
David L; Li Y; Ma J; Garner E; Zhang X; Wu H
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.
Liu Y; Song R; Gao Y; Li Y; Wang S; Liu HY; Wang Y; Hu YH; Shu HB
J Biol Chem; 2012 Jun; 287(24):20081-7. PubMed ID: 22528498
[TBL] [Abstract][Full Text] [Related]
27. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Juilland M; Thome M
Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
[TBL] [Abstract][Full Text] [Related]
28. Methods to Study CARD11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells.
Gewies A; Graß C; Krappmann D
Methods Mol Biol; 2021; 2366():125-143. PubMed ID: 34236636
[TBL] [Abstract][Full Text] [Related]
29. CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1.
Wang D; Matsumoto R; You Y; Che T; Lin XY; Gaffen SL; Lin X
Mol Cell Biol; 2004 Jan; 24(1):164-71. PubMed ID: 14673152
[TBL] [Abstract][Full Text] [Related]
30. Germline CBM-opathies: From immunodeficiency to atopy.
Lu HY; Biggs CM; Blanchard-Rohner G; Fung SY; Sharma M; Turvey SE
J Allergy Clin Immunol; 2019 May; 143(5):1661-1673. PubMed ID: 31060714
[TBL] [Abstract][Full Text] [Related]
31. MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.
Gehring T; Erdmann T; Rahm M; Graß C; Flatley A; O'Neill TJ; Woods S; Meininger I; Karayel O; Kutzner K; Grau M; Shinohara H; Lammens K; Feederle R; Hauck SM; Lenz G; Krappmann D
Cell Rep; 2019 Oct; 29(4):873-888.e10. PubMed ID: 31644910
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain.
Lamason RL; McCully RR; Lew SM; Pomerantz JL
Biochemistry; 2010 Sep; 49(38):8240-50. PubMed ID: 20799731
[TBL] [Abstract][Full Text] [Related]
33. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
[TBL] [Abstract][Full Text] [Related]
34. Picomolar zinc binding modulates formation of Bcl10-nucleating assemblies of the caspase recruitment domain (CARD) of CARD9.
Holliday MJ; Ferrao R; de Leon Boenig G; Estevez A; Helgason E; Rohou A; Dueber EC; Fairbrother WJ
J Biol Chem; 2018 Oct; 293(43):16803-16817. PubMed ID: 30206119
[TBL] [Abstract][Full Text] [Related]
35. MALT1 substrate cleavage: what is it good for?
Moud BN; Ober F; O'Neill TJ; Krappmann D
Front Immunol; 2024; 15():1412347. PubMed ID: 38863711
[TBL] [Abstract][Full Text] [Related]
36. A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.
Yin H; Karayel O; Chao YY; Seeholzer T; Hamp I; Plettenburg O; Gehring T; Zielinski C; Mann M; Krappmann D
Cell Mol Life Sci; 2022 Jan; 79(2):112. PubMed ID: 35099607
[TBL] [Abstract][Full Text] [Related]
37. CARD9 versus CARMA1 in innate and adaptive immunity.
Hara H; Saito T
Trends Immunol; 2009 May; 30(5):234-42. PubMed ID: 19359218
[TBL] [Abstract][Full Text] [Related]
38. The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
Lu HY; Bauman BM; Arjunaraja S; Dorjbal B; Milner JD; Snow AL; Turvey SE
Front Immunol; 2018; 9():2078. PubMed ID: 30283440
[TBL] [Abstract][Full Text] [Related]
39. Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease.
Yamamoto-Furusho JK; Fonseca-Camarillo G; Furuzawa-Carballeda J; Sarmiento-Aguilar A; Barreto-Zuñiga R; Martínez-Benitez B; Lara-Velazquez MA
J Inflamm (Lond); 2018; 15():13. PubMed ID: 30008619
[TBL] [Abstract][Full Text] [Related]
40. C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation.
Zhao XQ; Zhu LL; Chang Q; Jiang C; You Y; Luo T; Jia XM; Lin X
J Biol Chem; 2014 Oct; 289(43):30052-62. PubMed ID: 25202022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
